← All drafts
Draft #2033 submit failed Created Apr 28, 2026, 14:05:29

Pipeline run for this draft

Generated note

Retatrutide is investigational and not FDA-approved. https://www.lilly.com/news/stories/what-to-know-about-retatrutide The post combines results from the main obesity phase 2 trial and a MASLD liver-fat substudy; the papers do not report resting metabolic rate. NEJM says at least one antihypertensive was stopped, not all BP meds. https://www.nature.com/articles/s41591-024-03018-2 https://mediacenteratypon.nejmgroup-production.org/NEJMoa2301972.pdf

Source post

Retatrutide trial results are straight-up insane: •86% liver fat reduction •72% prediabetes reversal •41% completely off BP meds •14 mmHg blood pressure drop •Raises resting metabolic rate It crushes appetite and makes you burn more calories at rest. One compound. All of that. Mind officially blown. This is next-level. 🔥

Apr 27, 2026, 21:05:46 Open on X →

Pipeline steps

16 steps
  1. ✓
  2. ✓
  3. ✓
  4. ✓
  5. ✓
  6. ✓
  7. ✓
  8. ✓
  9. ✓
  10. ✓
  11. ✓
  12. ✓
  13. ✓
  14. ✓
  15. ✓
  16. ✓
Step #1

generate_note.pre_filter

Success
Started
Apr 28, 2026, 14:05:29
Finished
Apr 28, 2026, 14:13:48
Duration
—

Input snapshot

{
  "post_text": "[Target Post]\nRetatrutide trial results are straight-up insane:\n\n•86% liver fat reduction\n•72% prediabetes reversal\n•41% completely off BP meds\n•14 mmHg blood pressure drop\n•Raises resting metabolic rate\n\nIt crushes appetite and makes you burn more calories at rest.\n\nOne compound. All of that.\nMind officially blown. This is next-level. 🔥\n\n[Suggested source links from requests]\nhttps://x.com/realpeptides/status/2048841555595690307"
}

Output snapshot

{
  "has_factual_claims": true
}

! Submission error

X API request failed (403): {'detail': 'Failed to create a note. You’ve reached your daily limit for writing notes.', 'type': 'about:blank', 'title': 'Forbidden', 'status': 403}